000 -LEADER |
fixed length control field |
01613 a2200313 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
051207s xx 000 0 eng |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1522-3248; |
050 ## - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
AC1.S5 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
050 |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
Ojcius, David M., |
245 #0 - TITLE STATEMENT |
Title |
Can Chlamydia Be Stopped?. |
Statement of responsibility, etc. |
David M. Ojcius and others. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Name of publisher, distributor, etc. |
Scientific American, |
Date of publication, distribution, etc. |
2005. |
440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
SIRS Enduring Issues 2006. |
Number of part/section of a work |
Article 75, |
Name of part/section of a work |
Human Relations, |
International Standard Serial Number |
1522-3248; |
500 ## - GENERAL NOTE |
General note |
Articles Contained in SIRS Enduring Issues 2006. |
500 ## - GENERAL NOTE |
General note |
Originally Published: Can Chlamydia Be Stopped?, May 2005; pp. 72-79. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
"Ask the average American about chlamydia, and you will probably evoke an uneasy cringe. Most people think immediately of one of the world's most common sexually transmitted diseases (STDs). But the term actually refers to an entire genus of tiny bacteria that can ignite a variety of serious illnesses." (SCIENTIFIC AMERICAN) This article reveals how "recent discoveries are suggesting new ways to curtail the spread" of chlamydia, "a rampant sexually transmitted disease, the world's leading cause of preventable blindness and a possible contributor to heart disease." |
599 ## - |
-- |
Records created from non-MARC resource. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Apoptosis |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Atherosclerosis |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Chlamydia |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Chlamydia infections |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cytokines |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Eye |
General subdivision |
Diseases |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Immune response |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
T cells |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Vaccines |
General subdivision |
Research |
710 ## - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
ProQuest Information and Learning Company |
Title of a work |
SIRS Enduring Issues 2006, |
Name of part/section of a work |
Human Relations. |
International Standard Serial Number |
1522-3248; |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
|